HAMILTON, ON and BOSTON, June 4, 2024 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs), announced the ...
A UK company with lofty aspirations around sustainable space travel has test-fired a rocket engine powered in part by plastic waste. Pulsar Fusion's hybrid rocket engine is part of an ambitious ...
AstraZeneca today announced the successful completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback